{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T04:03:30Z","timestamp":1748145810383,"version":"3.41.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.1093\/jbmr\/zjae044","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T06:26:50Z","timestamp":1713767210000},"page":"375-376","source":"Crossref","is-referenced-by-count":4,"title":["Actionable disease insights from bedside-to-bench investigation in fibrodysplasia ossificans progressiva"],"prefix":"10.1093","volume":"39","author":[{"given":"Marc N","family":"Wein","sequence":"first","affiliation":[{"name":"Endocrine Unit , Harvard Medical School, , Boston, MA 02114 ,","place":["United States"]},{"name":"Massachusetts General Hospital , Harvard Medical School, , Boston, MA 02114 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology, Harvard School of Dental Medicine , Boston, MA 02115 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,21]]},"reference":[{"issue":"303","key":"2025052403510808400_ref1","doi-asserted-by":"crossref","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci Transl Med"},{"issue":"366","key":"2025052403510808400_ref2","doi-asserted-by":"crossref","first-page":"366ra163","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"2025052403510808400_ref3","doi-asserted-by":"crossref","first-page":"e10821","DOI":"10.1002\/jbm4.10821","article-title":"Palovarotene action against heterotopic ossification includes a reduction of local participating activin A-expressing cell populations","volume":"7","author":"Mundy","year":"2023","journal-title":"JBMR Plus"},{"issue":"3","key":"2025052403510808400_ref4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jbmr.4762","article-title":"Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of palovarotene for fibrodysplasia ossificans progressiva (FOP)","volume":"38","author":"Pignolo","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025052403510808400_ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","author":"Genetic Modifiers of Huntington's Disease, C","year":"2015","journal-title":"Cell"},{"issue":"24","key":"2025052403510808400_ref6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245821","article-title":"Genetic modifying factors of cystic fibrosis phenotype: a challenge for modern medicine","volume":"10","author":"Butnariu","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"2025052403510808400_ref7","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/s41467-021-23556-4","article-title":"Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes","volume":"12","author":"Goodrich","year":"2021","journal-title":"Nat Commun"},{"key":"2025052403510808400_ref8","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjae029","article-title":"Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice","author":"Lounev","year":"2024","journal-title":"J Bone Miner Res"},{"key":"2025052403510808400_ref9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.matbio.2022.10.002","article-title":"The gelatinases, matrix metalloproteinases 2 and 9, play individual roles in skeleton development","volume":"113","author":"Kalev-Altman","year":"2022","journal-title":"Matrix Biol"},{"issue":"11","key":"2025052403510808400_ref10","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jor.23216","article-title":"Location-dependent heterotopic ossification in the rat model: the role of activated matrix metalloproteinase 9","volume":"34","author":"Davis","year":"2016","journal-title":"J Orthop Res"},{"issue":"10","key":"2025052403510808400_ref11","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41591-023-02561-8","article-title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"29","author":"Di Rocco","year":"2023","journal-title":"Nat Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/4\/375\/59922904\/zjae044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/4\/375\/59922904\/zjae044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T07:51:13Z","timestamp":1748073073000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/39\/4\/375\/7655608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,21]]},"published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjae044","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"type":"print","value":"0884-0431"},{"type":"electronic","value":"1523-4681"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,4]]}}}